Trinh Pham Email

Sr. R&D and Catheter Technologies Manager . Venus Medtech

Current Roles

Employees:
57
Revenue:
$7.2M
About
Venus Medtech (Hangzhou) Inc. is a leading transcatheter heart valve medical device player in China in terms of implantation volume in 2018. The Company's self-developed product, VenusA-Valve, is the first transcather aortic heart valve replacement (“TAVR”) product approved by the National Medical Products Administration ("NMPA") and commercialized in China.
Venus Medtech Address

杭州, null
Venus Medtech Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.